Mackenzie Financial Corp Astrazeneca PLC Transaction History

Mackenzie Financial Corp

$63.2 Billion
Q2 2024

A detailed history of Mackenzie Financial Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Mackenzie Financial Corp holds 307,954 shares of AZN stock, worth $23.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

307,954

Previous 281,741 9.3%

Holding current value

$23.9 Million

Previous $19.1 Million 25.83%

% of portfolio

0.04%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $1.75 Million - $2.12 Million	26,213 Added 9.3%	307,954 $24 Million
Q1 2024 May 10, 2024	SELL	$61.03 - $69.57 $1.33 Million - $1.52 Million	-21,792 Reduced 7.18%	281,741 $19.1 Million
Q4 2023 Jan 30, 2024	SELL	$61.89 - $69.28 $680,913 - $762,218	-11,002 Reduced 3.5%	303,533 $20.4 Million
Q3 2023 Oct 25, 2023	SELL	$64.85 - $71.7 $2.15 Million - $2.38 Million	-33,172 Reduced 9.54%	314,535 $21.3 Million
Q2 2023 Aug 03, 2023	BUY	$69.91 - $75.81 $1.34 Million - $1.45 Million	19,124 Added 5.82%	347,707 $24.9 Million
Q1 2023 Apr 24, 2023	SELL	$63.15 - $71.6 $961,016 - $1.09 Million	-15,218 Reduced 4.43%	328,583 $22.8 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $203,829 - $264,854	-3,760 Reduced 1.08%	343,801 $23.3 Million
Q3 2022 Oct 07, 2022	SELL	$53.02 - $135.75 $1.17 Million - $3 Million	-22,128 Reduced 5.99%	347,561 $19.1 Million
Q2 2022 Aug 10, 2022	SELL	$59.26 - $71.14 $1.01 Million - $1.22 Million	-17,097 Reduced 4.42%	369,689 $24.4 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $1.87 Million - $2.25 Million	33,585 Added 9.51%	386,786 $25.7 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $160,655 - $189,830	-2,974 Reduced 0.83%	353,201 $20.6 Million
Q3 2021 Nov 08, 2021	BUY	$55.56 - $60.79 $7.54 Million - $8.25 Million	135,675 Added 61.53%	356,175 $21.4 Million
Q2 2021 Aug 11, 2021	BUY	$48.42 - $60.18 $353,466 - $439,314	7,300 Added 3.42%	220,500 $13.2 Million
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $594,216 - $685,944	12,600 Added 6.28%	213,200 $10.6 Million
Q4 2020 Feb 10, 2021	BUY	$48.52 - $58.02 $883,064 - $1.06 Million	18,200 Added 9.98%	200,600 $10 Million
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $769,515 - $885,950	14,500 Added 8.64%	182,400 $10 Million
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $814,590 - $1.05 Million	-18,900 Reduced 10.12%	167,900 $8.88 Million
Q1 2020 May 14, 2020	BUY	$37.79 - $51.33 $634,872 - $862,344	16,800 Added 9.88%	186,800 $8.34 Million
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $326,942 - $388,542	7,700 Added 4.74%	170,000 $8.48 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $461,379 - $522,905	11,500 Added 7.63%	162,300 $7.23 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $610,310 - $682,343	16,371 Added 12.18%	150,800 $6.23 Million
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $432,907 - $524,757	12,198 Added 9.98%	134,429 $5.44 Million
Q4 2018 Feb 06, 2019	BUY	$36.86 - $41.49 $3.41 Million - $3.84 Million	92,551 Added 311.83%	122,231 $4.64 Million
Q3 2018 Nov 15, 2018	BUY	$34.76 - $39.72 $78,105 - $89,250	2,247 Added 8.19%	29,680 $1.17 Million
Q2 2018 Aug 13, 2018	BUY	$34.55 - $37.05 $256,533 - $275,096	7,425 Added 37.11%	27,433 $963,000
Q1 2018 May 14, 2018	SELL	$32.97 - $36.63 $49,224 - $54,688	-1,493 Reduced 6.94%	20,008 $700,000
Q4 2017 Feb 13, 2018	BUY	$32.09 - $34.78 $242,407 - $262,728	7,554 Added 54.16%	21,501 $746,000
Q3 2017 Nov 13, 2017	BUY	$28.96 - $34.0 $71,936 - $84,456	2,484 Added 21.67%	13,947 $473,000
Q2 2017 Aug 14, 2017	BUY	N/A	11,463	11,463 $391,000

Others Institutions Holding AZN

# of Institutions

1,333

Shares Held

490M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $241B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Astrazeneca PLC Transaction History